| Year |
Citation |
Score |
| 2023 |
Larson RC, Kann MC, Graham C, Mount CW, Castano AP, Lee WH, Bouffard AA, Takei HN, Almazan AJ, Scarfó I, Berger TR, Schmidts A, Frigault MJ, Gallagher KME, Maus MV. Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. Nature Communications. 14: 7509. PMID 37980341 DOI: 10.1038/s41467-023-43416-7 |
0.308 |
|
| 2022 |
Mount CW, Gonzalez Castro LN. Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors. Antibodies (Basel, Switzerland). 11. PMID 35645204 DOI: 10.3390/antib11020031 |
0.316 |
|
| 2022 |
Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, Richards RM, Jiang L, Barsan V, Mancusi R, Geraghty AC, Good Z, Mochizuki AY, Gillespie SM, Toland AMS, ... ... Mount CW, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. PMID 35130560 DOI: 10.1038/s41586-022-04489-4 |
0.698 |
|
| 2020 |
Theruvath J, Sotillo E, Mount CW, Graef CM, Delaidelli A, Heitzeneder S, Labanieh L, Dhingra S, Leruste A, Majzner RG, Xu P, Mueller S, Yecies DW, Finetti MA, Williamson D, et al. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors. Nature Medicine. PMID 32341579 DOI: 10.1038/S41591-020-0821-8 |
0.61 |
|
| 2019 |
Mount CW, Yalçın B, Cunliffe-Koehler K, Sundaresh S, Monje M. Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity. Elife. 8. PMID 31625910 DOI: 10.7554/Elife.49291 |
0.71 |
|
| 2019 |
Majzner RG, Theruvath JL, Nellan A, Heitzeneder S, Cui Y, Mount CW, Rietberg SP, Linde MH, Xu P, Rota C, Sotillo E, Labanieh L, Lee DW, Orentas RJ, Dimitrov DS, et al. CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30655315 DOI: 10.1158/1078-0432.Ccr-18-0432 |
0.61 |
|
| 2019 |
Mount CW, Yalçın B, Cunliffe-Koehler K, Sundaresh S, Monje M. Author response: Monosynaptic tracing maps brain-wide afferent oligodendrocyte precursor cell connectivity Elife. DOI: 10.7554/Elife.49291.014 |
0.582 |
|
| 2018 |
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science (New York, N.Y.). 360: 331-335. PMID 29674595 DOI: 10.1126/Science.Aao4750 |
0.619 |
|
| 2018 |
Mount CW, Majzner RG, Sundaresh S, Arnold EP, Kadapakkam M, Haile S, Labanieh L, Hulleman E, Woo PJ, Rietberg SP, Vogel H, Monje M, Mackall CL. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M diffuse midline gliomas. Nature Medicine. PMID 29662203 DOI: 10.1038/S41591-018-0006-X |
0.633 |
|
| 2018 |
Majzner RG, Mount C, Sundaresh S, Arnold E, Kadapakkam M, Labanieh L, Woo P, Monje M, Mackall CL. Abstract PR04: GD2-directed chimeric antigen receptor T cells mediate potent antitumor effect and cure in xenograft models of diffuse intrinsic pontine glioma Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-Pr04 |
0.642 |
|
| 2018 |
Mount CW, Majzner R, Sundaresh S, Arnold EP, Kadapakkam M, Haile S, Labanieh L, Woo P, Rietberg SP, Vogel H, Monje M, Mackall CL. Abstract 958: Anti-GD2 chimeric antigen receptor T cells as a potent immunotherapy regimen in xenograft models of histone 3 K27M mutant diffuse midline glioma Immunology. 78: 958-958. DOI: 10.1158/1538-7445.Am2018-958 |
0.647 |
|
| 2018 |
Mount C, Majzner R, Sundaresh S, Arnold E, Kadapakkam M, Haile S, Labanieh L, Woo P, Rietberg S, Vogel H, Monje M, Mackall C. DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA Neuro-Oncology. 20: i56-i56. DOI: 10.1093/Neuonc/Noy059.129 |
0.569 |
|
| 2017 |
Mount CW, Monje M. Wrapped to Adapt: Experience-Dependent Myelination. Neuron. 95: 743-756. PMID 28817797 DOI: 10.1016/J.Neuron.2017.07.009 |
0.604 |
|
| 2017 |
Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, Hovestadt V, Escalante LE, Shaw ML, Rodman C, Gillespie SM, Dionne D, Luo CC, Ravichandran H, Mylvaganam R, ... Mount C, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science (New York, N.Y.). 355. PMID 28360267 DOI: 10.1126/Science.Aai8478 |
0.587 |
|
| 2017 |
Mount C, Majzner R, Sundaresh S, Arnold E, Kadapakkam M, Monje-Deisseroth M, Mackall C. Pdtm-39. Gd2-Directed Chimeric Antigen Receptor T Cells As A Potent Immunotherapy Regimen In Xenograft Models Of Diffuse Intrinsic Pontine Glioma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.802 |
0.361 |
|
| 2016 |
Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K, Fisher JM, Rodman C, Mount C, Filbin MG, Neftel C, Desai N, Nyman J, Izar B, Luo CC, et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature. PMID 27806376 DOI: 10.1038/Nature20123 |
0.586 |
|
| 2016 |
Filbin MG, Tirosh I, Escalante LE, Venteicher AS, Goumnerova L, Pelton K, Bandopadhayay P, Mount C, Slavc I, Czech T, Gojo J, Lavarino C, Mora J, Monje M, Kieran MW, et al. HG-110SINGLE-CELL TRANSCRIPTOME ANALYSIS IN PEDIATRIC HEMISPHERIC AND MIDLINE HIGH-GRADE GLIOMAS Neuro-Oncology. 18: iii74.1-iii74. DOI: 10.1093/Neuonc/Now073.106 |
0.572 |
|
| 2015 |
Venkatesh HS, Johung TB, Caretti V, Noll A, Tang Y, Nagaraja S, Gibson EM, Mount CW, Polepalli J, Mitra SS, Woo PJ, Malenka RC, Vogel H, Bredel M, Mallick P, et al. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell. 161: 803-16. PMID 25913192 DOI: 10.1016/J.Cell.2015.04.012 |
0.588 |
|
| 2014 |
Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, Barres BA, Woo PJ, Vogel H, Monje M. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science (New York, N.Y.). 344: 1252304. PMID 24727982 DOI: 10.1126/Science.1252304 |
0.727 |
|
| Show low-probability matches. |